ATE345277T1 - Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern - Google Patents

Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern

Info

Publication number
ATE345277T1
ATE345277T1 AT03793140T AT03793140T ATE345277T1 AT E345277 T1 ATE345277 T1 AT E345277T1 AT 03793140 T AT03793140 T AT 03793140T AT 03793140 T AT03793140 T AT 03793140T AT E345277 T1 ATE345277 T1 AT E345277T1
Authority
AT
Austria
Prior art keywords
formulation
gaseous medium
chamber
injectable pharmaceutical
medium
Prior art date
Application number
AT03793140T
Other languages
English (en)
Inventor
Steven K Macleod
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE345277T1 publication Critical patent/ATE345277T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/02—Internal fittings
    • B65D25/04—Partitions
    • B65D25/08—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents
    • B65D25/082—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents the partition being in the form of a plug or the like which is removed by increasing or decreasing the pressure within the container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2041—Separating means having removable plugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
AT03793140T 2002-08-21 2003-08-20 Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern ATE345277T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40498802P 2002-08-21 2002-08-21

Publications (1)

Publication Number Publication Date
ATE345277T1 true ATE345277T1 (de) 2006-12-15

Family

ID=31946796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793140T ATE345277T1 (de) 2002-08-21 2003-08-20 Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern

Country Status (10)

Country Link
US (1) US7387623B2 (de)
EP (1) EP1545994B1 (de)
JP (1) JP4416653B2 (de)
AT (1) ATE345277T1 (de)
AU (1) AU2003265511A1 (de)
CA (1) CA2494825C (de)
DE (1) DE60309731T2 (de)
ES (1) ES2273078T3 (de)
NO (1) NO328187B1 (de)
WO (1) WO2004018312A1 (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7275640B2 (en) * 2004-02-05 2007-10-02 Boston Scientific Scimed, Inc. Packaging for imparting anti-microbial properties to a medical device
US7789854B2 (en) * 2004-05-13 2010-09-07 Talamonti Anthony R Medical treatment kit and methods of use thereof
GB2414405B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414409B (en) * 2004-05-28 2009-11-18 Cilag Ag Int Injection device
GB2414403B (en) * 2004-05-28 2009-01-07 Cilag Ag Int Injection device
GB2414401B (en) 2004-05-28 2009-06-17 Cilag Ag Int Injection device
GB2414402B (en) * 2004-05-28 2009-04-22 Cilag Ag Int Injection device
GB2414400B (en) * 2004-05-28 2009-01-14 Cilag Ag Int Injection device
GB2414775B (en) * 2004-05-28 2008-05-21 Cilag Ag Int Releasable coupling and injection device
GB2414406B (en) 2004-05-28 2009-03-18 Cilag Ag Int Injection device
GB2414399B (en) * 2004-05-28 2008-12-31 Cilag Ag Int Injection device
GB2414404B (en) 2004-05-28 2009-06-03 Cilag Ag Int Injection device
BRPI0518790A2 (pt) * 2004-12-02 2008-12-09 Wyeth Corp formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
EP1853234A2 (de) * 2005-02-15 2007-11-14 Elan Pharma International Limited Aerosol und injizierbare formulierungen aus benzodiazepin in form von nanoteilchen
GB2424838B (en) * 2005-04-06 2011-02-23 Cilag Ag Int Injection device (adaptable drive)
GB2425062B (en) * 2005-04-06 2010-07-21 Cilag Ag Int Injection device
GB2424836B (en) * 2005-04-06 2010-09-22 Cilag Ag Int Injection device (bayonet cap removal)
GB2424835B (en) * 2005-04-06 2010-06-09 Cilag Ag Int Injection device (modified trigger)
GB2427826B (en) 2005-04-06 2010-08-25 Cilag Ag Int Injection device comprising a locking mechanism associated with integrally formed biasing means
GB2424837B (en) * 2005-04-06 2010-10-06 Cilag Ag Int Injection device
DE602005018480D1 (de) 2005-08-30 2010-02-04 Cilag Gmbh Int Nadelvorrichtung für eine vorgefüllte Spritze
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
US20110098656A1 (en) 2005-09-27 2011-04-28 Burnell Rosie L Auto-injection device with needle protecting cap having outer and inner sleeves
NZ573048A (en) 2006-05-25 2011-08-26 Bayer Healthcare Llc Reconstitution device
GB2438591B (en) * 2006-06-01 2011-07-13 Cilag Gmbh Int Injection device
GB2438593B (en) 2006-06-01 2011-03-30 Cilag Gmbh Int Injection device (cap removal feature)
GB2438590B (en) 2006-06-01 2011-02-09 Cilag Gmbh Int Injection device
US20080077116A1 (en) * 2006-09-12 2008-03-27 Rosemary Dailey Container for intravenous fluids
SI2071917T1 (sl) * 2006-09-29 2013-03-29 Infa S.A. Pakirni sistem za farmacevtske sestavke in komplet za intravensko aplikacijo
US20090258850A1 (en) * 2007-08-21 2009-10-15 Frincke James M Stabilized therapeutic compositions and formulations
US20090084804A1 (en) * 2007-10-01 2009-04-02 Hospira, Inc. Snap-over port cap
US8091727B2 (en) * 2007-11-08 2012-01-10 Hospira, Inc. Snap-over clamshell protective port cap
CN101932327A (zh) 2007-12-19 2010-12-29 詹森药业有限公司 与长效注射用帕潘立酮酯相关的给药方案
GB2461086B (en) * 2008-06-19 2012-12-05 Cilag Gmbh Int Injection device
GB2461087B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461085B (en) 2008-06-19 2012-08-29 Cilag Gmbh Int Injection device
GB2461089B (en) * 2008-06-19 2012-09-19 Cilag Gmbh Int Injection device
GB2461088B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Injection device
GB2461084B (en) * 2008-06-19 2012-09-26 Cilag Gmbh Int Fluid transfer assembly
TW201103590A (en) * 2009-06-02 2011-02-01 Sanofi Aventis Deutschland Medicated module with integral flow distribution system
TWI438009B (zh) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc 紫杉烷前－乳劑調配物及其製造與使用之方法
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
AU2011295038B2 (en) * 2010-08-27 2014-12-04 Sanofi-Aventis Deutschland Gmbh Medicated module with integral flow distribution system for injection device
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
WO2013070656A1 (en) * 2011-11-07 2013-05-16 Navinta Llc Sustained release suspension preparation for dextromethorphan
US20140377343A1 (en) * 2011-12-23 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
WO2013095320A1 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen formulations
EP2793856B1 (de) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Im mund zerfallende formulierungen aus flurbiprofen
US20150004229A1 (en) * 2011-12-27 2015-01-01 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
US20140336148A1 (en) * 2011-12-27 2014-11-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combinations of diacerein and non-steroidal inflammation drugs
CA3078563A1 (en) * 2011-12-29 2013-07-04 Omrix Biopharmaceuticals Ltd. Method and device for fast dissolution of solid protein composition
USD674104S1 (en) * 2012-03-23 2013-01-08 Fairchild Sabrina S Baby bottle with formula pouch
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014145767A1 (en) * 2013-03-15 2014-09-18 Lannett Company, Inc. Multi-chamber anesthetic delivery system
GB2515032A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Guide for an injection device
GB2515038A (en) 2013-06-11 2014-12-17 Cilag Gmbh Int Injection device
GB2515039B (en) 2013-06-11 2015-05-27 Cilag Gmbh Int Injection Device
GB2517896B (en) 2013-06-11 2015-07-08 Cilag Gmbh Int Injection device
GB201313368D0 (en) * 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
EP3043777B1 (de) * 2013-09-10 2020-04-22 Fresh Cut Development, LLC Sublinguales buprenorphinspray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
WO2016036588A1 (en) * 2014-09-03 2016-03-10 Merck Sharp & Dohme Corp. Pharmaceutical suspensions containing etoricoxib
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
WO2017149492A1 (en) 2016-03-02 2017-09-08 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
WO2017184880A1 (en) 2016-04-20 2017-10-26 Coherus Biosciences, Inc. A method of filling a container with no headspace
WO2019048906A1 (en) * 2017-09-07 2019-03-14 Teva Pharmaceutical Industries Ltd. INJECTABLE COMPOSITIONS OF MEDROXYPROGESTERONE ACETATE AND METHODS OF USE
MX2020002606A (es) * 2017-09-07 2020-10-05 Teva Pharma Composiciones inyectables de acetato de medroxiprogesterona y metodos de uso.
PL3829736T3 (pl) * 2018-07-27 2024-05-20 F. Hoffmann-La Roche Ag Sposób napełniania pojemników przynajmniej jednym odgazowanym produktem leczniczym i urządzenie do napełniania produktem leczniczym
AU2019334932B2 (en) 2018-09-07 2025-01-30 Family Health International D/B/A Fhi 360 Medroxyprogesterone acetate injectable compositions and methods of use
MX2018011142A (es) 2018-09-13 2019-10-10 Federico Amezcua Amezcua Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona.
CN113056482A (zh) * 2018-10-18 2021-06-29 默沙东公司 抗rsv抗体的制剂及其使用方法
CN120842406A (zh) 2018-10-31 2025-10-28 默沙东有限责任公司 抗人pd-1抗体晶体及其使用方法
KR20210089215A (ko) 2018-11-07 2021-07-15 머크 샤프 앤드 돔 코포레이션 항-lag3 항체 및 항-pd-1 항체의 공동-제제
US11559466B2 (en) * 2020-07-23 2023-01-24 Christopher A. Carew Covering assembly with coagulant compartment and uses thereof in a blood monitoring/management system
US20220287914A1 (en) * 2021-03-10 2022-09-15 Carol L. Ovans Cone-Shaped Bottle Insert
WO2024089634A1 (en) 2022-10-27 2024-05-02 Pfizer Inc. Immunogenic compositions against influenza and rsv
US20240252612A1 (en) 2022-12-11 2024-08-01 Pfizer Inc. Immunogenic compositions and uses thereof
CN115813855A (zh) * 2023-02-03 2023-03-21 苏州欧康维视生物科技有限公司 一种低浓度的阿托品药物产品及其制造方法
KR102830788B1 (ko) * 2023-03-22 2025-07-04 한국섬유소재연구원 염색물의 아릴아민 추출 시험용 염색물 시험편 용기 및 그 시험편 용기를 이용한 염색물 시험편의 아릴아민 추출 시험장치
WO2025186719A1 (en) 2024-03-06 2025-09-12 Pfizer Inc. Immunogenic compositions and uses thereof
US12343427B1 (en) * 2024-04-23 2025-07-01 Nivagen Pharmaceuticals, Inc. Stable intravenous diltiazem hydrochloride formulation and use thereof
WO2025230305A1 (ko) * 2024-04-30 2025-11-06 (주)메디톡스 담즙산 또는 이의 유도체를 포함하는 조성물 및 이를 포함하는 약학 패키지

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3087638A (en) * 1961-12-15 1963-04-30 Abbott Lab Closure assembly
US3464414A (en) * 1963-07-31 1969-09-02 Upjohn Co Mixing vial construction
US3457348A (en) 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
US4089432A (en) * 1977-05-06 1978-05-16 The Upjohn Company Vial and closure
AT389211B (de) * 1977-09-14 1989-11-10 Tivet Dev Ltd Verfahren und vorrichtung zur herstellung proteinhaltiger nahrungsmittel
US4258845A (en) 1979-11-20 1981-03-31 The Upjohn Company Activator closure for two-compartment vial
US4614267A (en) * 1983-02-28 1986-09-30 Abbott Laboratories Dual compartmented container
US4871354A (en) * 1986-07-24 1989-10-03 The West Company Wet-dry bag with lyphozation vial
US5336180A (en) * 1990-04-24 1994-08-09 Science Incorporated Closed drug delivery system
SE9201246D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
JPH05317383A (ja) * 1992-05-19 1993-12-03 Nissho Corp 薬剤容器との連通手段を備えた溶解液容器
US5385546A (en) 1992-06-24 1995-01-31 Science Incorporated Mixing and delivering system
US5335773A (en) * 1993-07-02 1994-08-09 Habley Medical Technology Corporation Multi-pharmaceutical storage, mixing and dispensing vial
US5462526A (en) * 1993-09-15 1995-10-31 Mcgaw, Inc. Flexible, sterile container and method of making and using same
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
CA2387628C (en) * 1999-10-18 2007-03-27 The Dial Corporation Apparatus and method for forming casingless sausages
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
WO2001087262A2 (en) 2000-05-15 2001-11-22 Pharmacia Italia S.P.A. Stabilized steroidal suspension
JP2004337318A (ja) * 2003-05-14 2004-12-02 Otsuka Pharmaceut Factory Inc 医療用複室容器及びその製造方法

Also Published As

Publication number Publication date
JP4416653B2 (ja) 2010-02-17
EP1545994B1 (de) 2006-11-15
NO20051372L (no) 2005-03-16
US7387623B2 (en) 2008-06-17
WO2004018312A1 (en) 2004-03-04
DE60309731D1 (de) 2006-12-28
CA2494825A1 (en) 2004-03-04
DE60309731T2 (de) 2007-06-28
CA2494825C (en) 2009-02-17
EP1545994A1 (de) 2005-06-29
JP2005536285A (ja) 2005-12-02
NO328187B1 (no) 2009-12-28
ES2273078T3 (es) 2007-05-01
AU2003265511A1 (en) 2004-03-11
US20040039366A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
DE60309731D1 (de) Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
AR020831A1 (es) DISPOSITIVO A BASE DE UNA CAPERUZA DE CIERRE, CAPERUZA DE CIERRE Y UTILIZACIoN DE LOS MISMOS.
MX9305277A (es) Monohidrato de 5-(2-4(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-dihidro-2h-indol-2-1-clorhidrato.
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
ES2129048T3 (es) Composicion estabilizada de hormona paratiroide.
BR0005549A (pt) Ampola para o acondicionamento de um lìquido de uso médico
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
SV2002000969A (es) Composicion parenteral reconstituible
CO5011053A1 (es) Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento
UY23466A1 (es) Composiciones de detergentes liquidos de lavanderia
ATE233305T1 (de) Verpackungsmaterial mit aktiver auslösung
MXPA02012160A (es) Composiciones medicinales las cuales contienen derivados de propenona.
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
ATE253940T1 (de) Stabile lösung von calcitriol zum verpacken in phiolen
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
CO4830457A1 (es) Preparados efervescentes
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
SI1200088T1 (en) Paracetamol and drotaverine containing composition
ATE288257T1 (de) Trinkbare pharmazeutische suspension von ibuprofen
AR026451A1 (es) Compuestos heterociclicos sililados
AR012972A1 (es) Forma farmaceutica para la administracion de paclitaxel, proceso para la preparacion de una composicion de paclitaxel lista para usar y uso de estacomposicion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties